PDLI R&D Expenses
Pdl Biopharma Inc · R&D Expenses

PDLI R&D Expenses
Latest reported$4.56Mperiod ending
PDLI TTM R&D Expenses ($25.60M → $4.56M)
TTM R&D Expenses
High-resolution chart · PNG
PDLI r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 4,564,000 | |
| 8,874,000 | |
| 8,295,000 | |
| 7,308,000 | |
| 6,871,000 | |
| 3,233,000 | |
| 3,031,000 | |
| 2,955,000 | |
| 2,878,000 | |
| 2,811,000 | |
| 6,408,000 | |
| 7,381,000 | |
| 8,539,000 | |
| 9,867,000 | |
| 5,586,000 | |
| 3,820,000 | |
| 1,933,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 44,718,000 | |
| 85,118,000 | |
| 132,799,000 | |
| 159,881,000 | |
| 171,127,000 | |
| 197,813,000 | |
| 205,757,000 | |
| 244,072,000 | |
| 258,988,000 | |
| 254,514,000 | |
| 260,660,000 | |
| 242,222,000 | |
| 220,822,000 | |
| 198,549,000 | |
| 172,039,000 | |
| 155,279,000 | |
| 133,125,000 | |
| 124,795,000 | |
| 122,563,000 | |
| 115,141,000 | |
| 110,320,000 | |
| 99,369,000 | |
| 82,732,000 | |
| 75,665,000 | |
| 67,466,000 | |
| 61,182,000 | |
| 57,977,000 | |
| 56,098,000 | |
| 54,255,000 | |
| 51,688,000 | |
| 52,172,000 | |
| 49,949,000 | |
| 46,928,000 | |
| 44,937,000 | |
| 42,335,000 | |
| 42,127,000 | |
| 40,585,000 | |
| 38,869,000 | |
| 36,100,000 | |
| 33,600,000 | |
| 34,600,000 | |
| 33,400,000 | |
| 31,500,000 | |
| 29,100,000 | |
| 26,500,000 | |
| 25,500,000 | |
| 25,600,000 | |
| 25,800,000 | |
| 28,000,000 |